Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patientsAlexander Scheiter, Kirsten Utpatel, Sabine Einhell et al.|BMC Medicine|2026Cited by 2
Additional file 1 of Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patientsAlexander Scheiter, Kirsten Utpatel, Simon Mellin et al.|Open MIND|2026Cited by 0
Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patientsAlexander Scheiter, Kirsten Utpatel, Simon Mellin et al.|Figshare|2026Cited by 0
Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patientsAlexander Scheiter, Kirsten Utpatel, Simon Mellin et al.|Figshare|2026Cited by 0
PS2-05-19: Immuno- and Molecular-Profiling of Breast Cancer Metastasis in the CNSNiklas Abele, Ramona Erber, Mandy Berner et al.|Clinical Cancer Research|2026Cited by 0